176 related articles for article (PubMed ID: 37856996)
1. Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings.
Akkus S; Elkhooly M; Amatya S; Shrestha K; Sharma K; Kagzi Y; Khan E; Gupta R; Piquet AL; Jaiswal S; Wen S; Tapia M; Samant R; Sista SR; Sriwastava S
J Neurol Sci; 2023 Nov; 454():120830. PubMed ID: 37856996
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune encephalitis and paraneoplastic syndromes in Turkey: a multi-centre study.
Gozubatik-Celik RG; Gul ZB; Bilgin EB; Yildiz MU; Yenidunya O; Misirli H; Celik HT; Kurtulus F; Yaman A; Domac F; Karaci R; Cokar O; Culha Oktar A; Emre Toprak U; Yavuz N; Dalgıc E; Ozen Barut B; Dogan Ak P; Ozgenc CI; Bulbul NG; Atmaca MM; Gokyigit FM; Gürkan ZM; Pazarci N; Surmeli R; Kale N; Yildirim Z; Yayla V; Sozer N; Cabalar M; Delen F; Ucler S; Unal E; Sungur MA; Sen A; Atakli D; Soysal A
Neurol Sci; 2022 Jul; 43(7):4393-4403. PubMed ID: 35211811
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic Neurologic Disorders.
Gilligan M; McGuigan C; McKeon A
Curr Neurol Neurosci Rep; 2023 Mar; 23(3):67-82. PubMed ID: 36781586
[TBL] [Abstract][Full Text] [Related]
6. A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values.
Seluk L; Taliansky A; Yonath H; Gilburd B; Amital H; Shoenfeld Y; Kivity S
Clin Immunol; 2019 Feb; 199():29-36. PubMed ID: 30543927
[TBL] [Abstract][Full Text] [Related]
7. Severe central and peripheral paraneoplastic demyelination associated with tumours of the ovaries.
Jurkiewicz E; Kotulska K; Nowak K; Malczyk K; Borkowska J; Bilska M
Childs Nerv Syst; 2015 Sep; 31(9):1601-6. PubMed ID: 25966874
[TBL] [Abstract][Full Text] [Related]
8. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.
Lorusso L; Precone V; Hart IK; Giometto B; Pezzani R; Ngonga GK; Ngonga GKNK; Paolacci S; Ferrari D; Ricevuti G; Marshall E; Bertelli M
J Biosci; 2021; 46():. PubMed ID: 33709965
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
11. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and immunopathology of paraneoplastic disorders.
Quinot V; Höftberger R
Handb Clin Neurol; 2024; 200():33-54. PubMed ID: 38494287
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
14. Updates in the Management of Paraneoplastic Syndrome.
Verma N; Jaffer MH; Kolli AS; Mokhtari S
Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic antibodies targeting intracellular antigens.
Linnoila JJ
Handb Clin Neurol; 2024; 200():335-346. PubMed ID: 38494288
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurological syndromes.
Graus F; Dalmau J
Curr Opin Neurol; 2012 Dec; 25(6):795-801. PubMed ID: 23041955
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic Neurologic Syndromes].
Tanaka K
Brain Nerve; 2023 Jun; 75(6):755-762. PubMed ID: 37287359
[TBL] [Abstract][Full Text] [Related]
18. PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit.
Hadjivassiliou M; Alder SJ; Van Beek EJ; Hanney MB; Lorenz E; Rao DG; Sharrack B; Tindale WB
Acta Neurol Scand; 2009 Mar; 119(3):186-93. PubMed ID: 18855873
[TBL] [Abstract][Full Text] [Related]
19. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
Graus F
Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
[TBL] [Abstract][Full Text] [Related]
20. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
